Prognostic factor | Hazards ratio (95% CI) | P value |
---|---|---|
ECOG PS ≥2 | 13.3 (2.4–75.2) | .01 |
HGBCL | 7.6 (1.4–43.0) | .02 |
Age | 1.0 (0.9–1.1) | .42 |
Gender | 1.0 (0.2–5.6) | .97 |
Number of extranodal sites ≥2 | 1.8 (0.4–8.9) | .47 |
Ann Arbor stage III/IV | 0.8 (0.2–4.8) | .87 |
Bulk | 0.8 (0.7–3.9) | .77 |
IPI high ≥4–5 | 1.6 (0.3–9.0) | .56 |
LDH elevated | 1.2 (0.2–6.7) | .81 |
B-symptoms | 1.9 (0.4–9.6) | .42 |
ADCmean | 2.3 (1.1–5.5) | .02 |
ADCmin | 1.8 (0.8–4.2) | .19 |
MTV | 1.4 (0.7–2.7) | .34 |
MTV/ADCmean | 1.8 (0.2–14.4) | .58 |
MTV/ADCmin | 1.0 (0.2–4.6) | .96 |